Swiss stocks – Factors to watch on July 8ReutersZURICH, July 8 (Reuters) – The following are some of the main factors expected to affect Swiss stocks on Tuesday. NOVARTIS. Swiss drugmaker Novartis said on Monday U.S. health regulators have granted its personalised cell therapy CLT019 …Novartis AG receives Breakthrough Therapy tag for CTL019 leukemia treatmentGant DailyNovartis Leukemia Treatment CTL019 Gets FDA Breakthrough Therapy StatusRTT NewsUS regulators fast-track novel leukemia therapyMedical XpressThe Oncology Reportall 39 news articles …Read Full Story
Swiss stocks - Factors to watch on July 8 - Reuters
Real Estate of Cebu
